Endoscopic craniofacial resection. Indications and technical aspects

Acta Otorrinolaringol Esp. 2012 Nov-Dec;63(6):413-20. doi: 10.1016/j.otorri.2012.04.004. Epub 2012 Jun 12.
[Article in English, Spanish]

Abstract

Introduction: Anterior craniofacial resection (CFR) is a standardised procedure for the treatment of tumours involving the anterior skull base. We present our experience in the endoscopic treatment of these tumours.

Material and method: A retrospective analysis was performed of patients treated by endoscopic anterior CFR in our Department from 2004 until 2011.

Results: Thirty-two patients were analysed. Mean follow-up was 28 months (range: 6-84 months). The most frequent pathological entity was adenocarcinoma (60%), followed by undifferentiated carcinoma (13%). According to TNM classification, malignant epithelial tumour staging was T3 in 9%, T4a in 53% and T4b in 19% of the malignant epithelial tumours. The complication rate was 6% and the resection was complete in 91% of cases. During follow-up, 9% of patients developed recurrence. The 5-year overall survival rate was 70% and the 5-year disease-free survival rate was 85%

Conclusion: These results seem to indicate that properly planned endoscopic CFR may be a valid alternative to traditional open approaches for the management of malignancies of the anterior skull base.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Endoscopy / methods*
  • Facial Bones / surgery*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Skull / surgery*
  • Skull Base Neoplasms / surgery*
  • Young Adult